Carcinoid syndrome risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 16: | Line 16: | ||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{WS}} | |||
{{WH}} | {{WH}} | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Endocrinology]] | |||
[[Category:Pulmonology]] | |||
[[Category:Hematology]] |
Revision as of 19:54, 15 July 2016
Carcinoid syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Carcinoid syndrome risk factors On the Web |
American Roentgen Ray Society Images of Carcinoid syndrome risk factors |
Risk calculators and risk factors for Carcinoid syndrome risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overiew
Common risk factors in the development of carcinoid syndrome include age (50 years or older), female gender, family history of multiple endocrine neoplasia type 1 and neurofibromatosis type 1, atrophic gastritis, pernicious anemia, and Zollinger-Ellison syndrome.[1]
Risk Factors
Common risk factors in the development of carcinoid syndrome include:[1]
- Age (50 years or older)
- Female gender
- Family history of multiple endocrine neoplasia type 1
- Family history of neurofibromatosis type 1
- Atrophic gastritis
- Pernicious anemia
- Zollinger-Ellison syndrome
References
- ↑ 1.0 1.1 Health history can affect the risk of gastrointestinal carcinoid tumors. National Cancer Institute. http://www.cancer.gov/types/gi-carcinoid-tumors/patient/gi-carcinoid-treatment-pdq